American Society of Hirudotherapy

Calcaneal Heel Spur (Symptomatic)

Investigational use for symptomatic plantar calcaneal spur; distinguished from plantar fasciitis by radiographic spur with localized pain.

Tier C — InvestigationalInvestigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Last Updated: November 10, 2026 · ASH Editorial · based on the books

Patient Summary

Is this FDA-cleared for this use?
Not FDA-cleared for symptomatic heel spur. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is Tier C investigational; the only clinical data identified are from one small uncontrolled study in plantar fasciitis.
What evidence exists?
Tier C (investigational). One small uncontrolled study in plantar fasciitis (n=20, published 2020; 30 percent of patients had a heel spur on X-ray) reported falling heel-pain scores from day 1 to day 43. There are no controlled trials. Plantar calcaneal spur is a radiographic finding frequently coexisting with plantar fasciitis but distinct clinically — pain is well-localized to the spur point. Evidence-based first-line management is plantar fascia and gastrocnemius stretching, heel-cushioning orthotics, NSAIDs, and (selectively) corticosteroid injection. Spurs themselves rarely require surgical excision.
Main risks
  • Bleeding from bite sites for 6 to 24 hours after detachment
  • Bruising and tenderness over the heel pad for 5 to 14 days
  • Local skin infection or Aeromonas infection (foot is a higher-risk anatomic site)
  • Allergic reaction to leech saliva
  • Temporary worsening of heel pain after the procedure
  • Catastrophic risk if a leech is placed on a diabetic or insensate foot (this is contraindicated)
  • Delay of stretching, orthotics, and corticosteroid injection, which are evidence-based
  • Failure to identify alternative diagnoses (tarsal tunnel, plantar fascia rupture, calcaneal stress fracture)
Who should not consider this
  • Patients with diabetes and peripheral neuropathy (insensate foot is high-risk)
  • Patients within 4 weeks of local corticosteroid injection
  • Patients with active foot infection or open wound
  • Patients with peripheral vascular disease and reduced ankle-brachial index
  • Patients on anticoagulants or with anemia
  • Patients who have not trialed stretching, heel cushioning, and NSAIDs
What to ask your clinician
  • Has the spur been confirmed radiographically and is it consistent with the location of pain?
  • Have I trialed at least 12 weeks of plantar fascia and gastrocnemius stretching?
  • Am I using a heel-cushioning orthotic?
  • Have alternative diagnoses (tarsal tunnel, stress fracture) been excluded?
  • Where exactly will the leech be placed, and what is the foot-care plan?
  • What is the realistic expected benefit, given one small case series?
When to seek urgent care
  • Sudden severe heel pain after a snap or pop (rule out plantar fascia rupture)
  • New ulceration or non-healing wound on the foot
  • Spreading redness, warmth, pus, or red streaks at any bite site or on the foot
  • Fever above 38.0 C / 100.4 F or chills
  • Bleeding from a bite site lasting more than 24 hours
  • Numbness or tingling in the toes after the procedure

What this does NOT mean

  • It does not remove or change the bony spur itself.
  • It does not substitute for plantar fascia stretching and heel cushioning, which are first-line.
  • It is not appropriate on a diabetic or insensate foot.
  • Only one small uncontrolled study (in plantar fasciitis) was identified; benefit is uncertain beyond placebo, natural recovery or concurrent therapy.

Clinical Profile

Category
Musculoskeletal
ICD-10
M77.30, M77.31, M77.32
Safety tier
Low

Evidence Summary

A plantar calcaneal spur is a radiographic finding that frequently coexists with plantar fasciitis but is clinically distinct, with pain well-localized to the spur point. No controlled clinical trial of leech therapy for calcaneal heel spur was identified. The closest evidence is one small uncontrolled study in plantar fasciitis (Nambiar and George 2020; 20 patients, 30 percent of whom had a heel spur on X-ray) that reported falling pain and tenderness scores over 43 days. Use is investigational, with a rationale presumed to overlap with plantar fasciitis (local anti-inflammatory effects). First-line management remains stretching, orthotics, and selective corticosteroid injection; spurs do not require excision unless very large.

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)

Contraindications

  • Hemophilia or another bleeding disorder
  • Taking anticoagulants (blood thinners such as warfarin or heparin)
  • Anemia or suppressed blood formation
  • Low blood pressure, shock, collapse or fainting
  • Severe wasting (cachexia)
  • Intolerance of leeches or a history of severe allergic reactions
  • Pregnancy
  • Stomach or duodenal ulcer, erosive gastritis
  • Acute infectious disease or high fever
  • Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
  • Drinking alcohol at the time of treatment
  • No consent from the patient
  • Recent local corticosteroid injection (<4 weeks)
  • Diabetic foot or peripheral neuropathy
  • Active foot infection

Related Conditions

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.